CD388 clinical trials

A long-term study testing the safety and effects of a new yearly antiviral treatment (CD388) in healthy people

This study looks at a new yearly treatment (CD388) for flu in healthy people. If you were in a previous CD388 study, you might be eligible to get two yearly doses over two years, helping us understand its long-term safety and effects.